Ectopic expression of N-acetylglucosamine 6-O-sulfotransferase 2 in chemotherapy-resistant ovarian adenocarcinomas

Glycoconjugate Journal

Volumn 23, Issue 5-6, 2006, Pages 453-460

  Kanoh, Akira ^a   Seko, Akira ^b,c   Ideo, Hiroko ^b,c   Yoshida, Midori ^d   Nomoto, Mitsuharu ^e   Yonezawa, Suguru ^e   Sakamoto, Masaru ^f   Kannagi, Reiji ^g   Yamashita, Katsuko ^b,c  

^a TAIHCO Pharmaceutical Co Ltd   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f Kyoundo Hospital   (Japan)

^g AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Mucinous adenocarcinoma; Ovarian cancer; Sulfated glycan; Sulfotransferase; Tumor marker

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOHYDRATE; L SELECTIN; LIGAND; MONOCLONAL ANTIBODY; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE 2; N ACETYLGLUCOSAMINYLTRANSFERASE; POLYCLONAL ANTIBODY; SULFOTRANSFERASE; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CANCER RESISTANCE; CARBOHYDRATE ANALYSIS; CELL SPECIFICITY; CLEAR CELL CARCINOMA; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYSTADENOMA; ENDOMETRIOID CARCINOMA; ENZYME ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, NEOPLASM; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; SULFOTRANSFERASES; TUMOR CELLS, CULTURED;

EID: 33746920369     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-006-6979-6     Document Type: Article

References (27)

1. Rubin, S.C., Wong, G.Y., Curtin, J.P., Barakat, R.R., Hakes, T.B., Hoskins, W.J.: Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging. Obstet. Gynecol. 82, 143-47 (1993)
2. Hogberg, T., Carstensen, J., Simonsen, E.: Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer. Gynecol. Oncol. 48, 38-49 (1993)
3. Shih, IeM., Kurman, R.J.: Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164, 1511-18 (2004)
4. Omura, G.A., Brady, M.F., Homesley, H.D., Yordan, E., Major, F.J., Buchsbaum, H.J., Park, R.C.: Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J. Clin. Oncol. 9, 1138-50 (1991)
5. Jacobs, I.J., Skates, S., Davies, A.P., Woolas, R.P., Jeyerajah, A., Weidemann, P., Sibley, K., Oram, D.H.: Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. BMJ 313, 1355-58 (1996)
6. Jacobs, I.J., Skates, S.J., MacDonald, N., Menon, U., Rosenthal, A.N., Davies, A.P., Woolas, R., Jeyarajah, A.R., Sibley, K., Lowe, D.G., Oram, D.H.: Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 353, 1207-10 (1999)
7. Bast, R.C. Jr., Xu, F.J., Yu, Y.H., Barnhill, S., Zhang, Z., Mills, G.B.: CA 125: The past and the future. Int. J. Biol. Markers 13, 179-87 (1998)
8. Seko, A., Nagata, K., Yonezawa, S., Yamashita, K.: Ectopic expression of a GlcNAc 6-O-sulfotransferase, GlcNAc6ST-2, in colonic mucinous adenocarcinoma. Glycobiology 12, 379-88 (2002)
9. Fukuda, M., Hiraoka, N., Akama, T.O., Fukuda, M.N.: Carbohydrate- modifying sulfotransferases: structure, function, and pathophysiology. J. Biol. Chem. 276, 47747-50 (2001)
10. Bistrup, A., Bhakta, S., Lee, J.K., Belov, Y.Y., Gunn, M.D., Zuo, F.R., Huang, C.C., Kannagi, R., Rosen, S.D., Hemmerich, S.: Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin. J. Cell Biol. 145, 899-910 (1999)
11. Hemmerich, S., Bistrup, A., Singer, M.S., van Zante, A., Lee, J.K., Tsay, D., Peters, M., Carminati, J.L., Brennan, T.J., Carver-Moore, K., Leviten M et al.: Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity 15, 237-47 (2001)
12. Yeh, J.C., Hiraoka, N., Petryniak, B., Nakayama, J., Ellies, L.G., Rabuka, D., Hindsgaul, O., Marth, J.D., Lowe, J.B., Fukuda, M.: Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase. Cell 105, 957-69 (2001)
13. Mitsuoka, C., Sawada-Kasugai, M., Ando-Furui, K., Izawa, M., Nakanishi, H., Nakamura, S., Ishida, H., Kiso, M., Kannagi, R.: Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X. J. Biol. Chem. 273, 11225-33 (1998)
14. Uchimura, K., Muramatsu, H., Kadomatsu, K., Fan, Q.W., Kurosawa, N., Mitsuoka, C., Kannagi, R., Habuchi, O., Muramatsu, T.: Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase. J. Biol. Chem. 273, 22577-83 (1998)
15. Seko, A., Sumiya, J., Yonezawa,, S., Nagata, K., Yamashita, K.: Biochemical differences between two types of N-acetylglucosamine:- 6sulfotransferases in human colonic adenocarcinomas and the adjacent normal mucosa: Specific expression of a GlcNac:-6sulfotransferase in mucinous adenocarcinoma. Glycobiology 10, 919-29 (2000)
16. Lee, J.K., Bhakta, S., Rosen, S.D., Hemmerich, S.: Cloning and characterization of a mammalian N-acetylglucosamine-6-sulfotransferase that is highly restricted to intestinal tissue, Biochem. Biophys. Res. Coomun. 263, 543-9 (1999)
17. Uchimura, K., El-Fasakhany, F.M., Hori, M., Hemmerich, S., Blink, S.E., Kansas, G.S., Kanamori, A., Kumamoto, K., Kannagi, R., Muramatsu, T.: Specificities of N-acetylglucosamine-6-O-sulfotransferases in relation to L-selectin ligand synthesis and tumor-associated enzyme expression. J. Biol. Chem. 277, 3979-84 (2002)
18. Federici, M.F., Kudryashov, V., Saigo, P.E., Finstad, C.L., Lloyd, K.O.: Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int. J. Cancer 81, 193-98 (1999)
19. Tamada, Y., Iida, S., Aoki, D., Nozawa, S., Irimura, T.: Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines. Oncol. Res. 11, 233-41 (1999)
20. Phillips, M.L., Nudelman, E., Gaeta, F.C., Perez, M., Singhal, A.K., Hakomori, S., Paulson, J.C.: ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250, 1130-32 (1990)
21. Takada, A., Ohmori, K., Yoneda, T., Tsuyuoka, K., Hasegawa, A., Kiso, M., Kannagi, R.: Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53, 354-61 (1993)
22. Martin-Satue, M., Marrugat, R., Cancelas, J.A., Blanco, J.: Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res. 58, 1544-50 (1998)
23. Weston, B.W., Hiller, K.M., Mayben, J.P., Manousos, G.A., Bendt, K.M., Liu, R., Cusack, J.C. Jr.: Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res. 59, 2127-35 (1999)
24. Ichikawa, Y., Nishida, M., Suzuki, H., Yoshida, S., Tsunoda, H., Kubo, T., Uchida, K., Miwa, M.: Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res. 54, 33-35 (1994)
25. Zhang, H., Evertsson, S., Sun, X.: Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum. Int. J. Oncol. 14, 1057-61 (1999)
26. Schuijer, M., Berns, E.M.: TP53 and ovarian cancer. Hum. Mutat. 21, 285-91 (2003)
27. Inoue, M., Ton, S.M., Ogawa, H., Tanizawa, O.: Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. Am. J. Clin. Pathol. 96, 711-16 (1991)